Language
English
Publication Date
6-4-2025
Journal
Journal of Clinical Medicine
DOI
10.3390/jcm14113975
PMID
40507737
PMCID
PMC12155839
PubMedCentral® Posted Date
6-4-2025
PubMedCentral® Full Text Version
Post-print
Abstract
Oxygen (O2) is vital for cellular development, function, proliferation, and repair, underscoring its critical role in organogenesis. Both hypoxia (reduced tissue O2) and hyperoxia (excess tissue O2), when prolonged, can trigger inflammation and oxidative stress, contributing to acute and long-term cardiopulmonary and neurodevelopmental morbidity. In sick neonates, immature defense mechanisms and coexisting morbidities demand nuanced and sometimes opposing strategies for O2 saturation targets and therapeutic titration. Most current neonatal O2 targeting guidelines are based on animal models or small clinical studies, resulting in recommendations with limited evidence. This narrative review aims to provide an updated overview of the physiological roles of O2 in development, its delivery and consumption, approaches to O2 saturation monitoring, and therapeutic targeting in neonates under both normal and pathological conditions. We also highlight key knowledge gaps and propose directions for future research on neonatal O2 saturation targeting.
Keywords
neonatal SpO2, bronchopulmonary dysplasia, pulmonary hypertension, retinopathy of prematurity
Published Open-Access
yes
Recommended Citation
Almudares, Faeq; Gandhi, Bheru; Davies, Jonathan; et al., "Oxygen Saturation Targeting in the Neonatal Intensive Care Unit" (2025). Faculty and Staff Publications. 5896.
https://digitalcommons.library.tmc.edu/baylor_docs/5896